ESX1 and neoplasm: Our results indicate that ESX-1 drives newly recruited uninfected bystanders into an inflammatory phenotype with parallels to neutrophils that promote tumor inflammation and growth, often characterized by expression of cc-chemokines and PDL1, and an ability to regulate both CD64+ myeloid cells and T cell responses (39, 40).